Olema Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Olema Pharmaceuticals

09/05/2023 23:24

* Olema Pharmaceuticals Inc  OLMA.OQ  reported a quarterly
adjusted loss of 70 cents​​ per share for the quarter ended in
March. The mean expectation of six analysts for the quarter was
for a loss of 66 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Olema Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 70 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Olema Pharmaceuticals Inc shares had risen by 89.3% this
quarter and gained 168.2% so far this year.
    * The company reported a quarterly loss of $28.29 million.
    * Wall Street's median 12-month price target for Olema
Pharmaceuticals Inc is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 10:24 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.66          -0.70          Missed
 Dec. 31 2022      -0.65          -0.65          Met
 Sep. 30 2022      -0.77          -0.57          Beat
 Jun. 30 2022      -0.64          -0.82          Missed